Stay updated on Arimoclomol Early Access Program in US Patients With NPC Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page.

Latest updates to the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page
- Check6 days agoChange DetectedThe revision history shows a minor addition of Revision: v3.3.2 and removal of Revision: v3.3.1, which are administrative logs and do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedThe version history now shows a new revision v3.3.1 and removes the older revision v3.2.0 from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the government funding and operating status disclaimer from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check35 days agoChange DetectedThe new screenshot shows only a visual/layout refresh of the page; the core data (study history, status, and contacts/locations) appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference11%

- Check71 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive changes.SummaryDifference0.3%

Stay in the know with updates to Arimoclomol Early Access Program in US Patients With NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page.